sarakan limited
sarakan limited Company Information
Company Number
01028133
Website
www.sarakan.co.ukRegistered Address
g r lane sisson road, gloucester, gloucestershire, GL2 0GR
Industry
Manufacture of basic pharmaceutical products
Telephone
01452524012
Next Accounts Due
April 2025
Group Structure
View All
Shareholders
g r lane health products ltd 100%
sarakan limited Estimated Valuation
Pomanda estimates the enterprise value of SARAKAN LIMITED at £0 based on a Turnover of £0 and 1.14x industry multiple (adjusted for size and gross margin).
sarakan limited Estimated Valuation
Pomanda estimates the enterprise value of SARAKAN LIMITED at £0 based on an EBITDA of £0 and a 5.36x industry multiple (adjusted for size and gross margin).
sarakan limited Estimated Valuation
Pomanda estimates the enterprise value of SARAKAN LIMITED at £2 based on Net Assets of £1 and 2.18x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sarakan Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Sarakan Limited Overview
Sarakan Limited is a live company located in gloucestershire, GL2 0GR with a Companies House number of 01028133. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in October 1971, it's largest shareholder is g r lane health products ltd with a 100% stake. Sarakan Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Sarakan Limited Health Check
There is insufficient data available to calculate a health check for Sarakan Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Sarakan Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (148)
- Sarakan Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Sarakan Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Sarakan Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Sarakan Limited
- - Industry AVG
sarakan limited Credit Report and Business Information
Sarakan Limited Competitor Analysis
Perform a competitor analysis for sarakan limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
sarakan limited Ownership
SARAKAN LIMITED group structure
Sarakan Limited has no subsidiary companies.
Ultimate parent company
2 parents
SARAKAN LIMITED
01028133
sarakan limited directors
Sarakan Limited currently has 2 directors. The longest serving directors include Mr Paul Whatley (Jan 2008) and Mrs Janet Groves (Jan 2008).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Whatley | United Kingdom | 66 years | Jan 2008 | - | Director |
| Mrs Janet Groves | United Kingdom | 72 years | Jan 2008 | - | Director |
SARAKAN LIMITED financials
Sarakan Limited's latest turnover from July 2023 is 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Sarakan Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Gross Profit | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Admin Expenses | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 15 | ||||||||||
| Interest Receivable | 0 | 0 | 0 | 0 | 55 | ||||||||||
| Pre-Tax Profit | 0 | 0 | 0 | 0 | 40 | ||||||||||
| Tax | 0 | 0 | 0 | 0 | -33 | ||||||||||
| Profit After Tax | 0 | 0 | 0 | 0 | 7 | ||||||||||
| Dividends Paid | 0 | 0 | 0 | 9,655 | 0 | ||||||||||
| Retained Profit | 0 | 0 | 0 | -9,655 | 7 | ||||||||||
| Employee Costs | 0 | 0 | 0 | 0 | |||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* | 0 | 0 | 0 | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 9,825 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 9,825 |
| total assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 9,825 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169 |
| net assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 9,656 |
| total shareholders funds | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 9,656 |
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Tax | 0 | 0 | 0 | 0 | -33 | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 | 0 | -9,825 | 9,825 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -169 | 169 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 0 | 0 | 0 | -1 | -9,689 | ||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 40 | ||||||||||
| cash flow from financing | 0 | 0 | 0 | 9,656 | 9,689 | ||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
P&L
July 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
1
0%
total assets
1
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
sarakan limited company details
company number
01028133
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
October 1971
age
53
accounts
Dormant
ultimate parent company
previous names
N/A
incorporated
UK
address
g r lane sisson road, gloucester, gloucestershire, GL2 0GR
last accounts submitted
July 2023
sarakan limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to sarakan limited.
sarakan limited Companies House Filings - See Documents
| date | description | view/download |
|---|
